MSLE
Satellos Bioscience Inc. Common Stock
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$8.97
−1.21%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-57.3%
Return on equity
-52.2%
Return on assets
-59.3%
Return on invested capital
0.00x
Asset turnover
-$28.7M
Cash from operations
$2.91
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026